Andy Stergachis, PhD, MS
Adjunct Professor, Department of Pharmacy
Interim Chair, Pathobiology
Office: Suite 400
Northwest Center for Public Health Practice
1107 NE 45th Street Northwest
Seattle, WA 98105
Dr. Stergachis' research interests are pharmacoepidemiology and the epidemiology of biological and chemical hazards. Through his affiliation with the Northwest Center for Public Health Practice, he focuses on education, training and research in emergency preparedness with the public health and clinical practice community. He is also affiliated with the Pharmaceutical Outcomes Research and Policy program. His current research includes studies of adverse events associated with biologics and other types of pharmaceuticals. He has served on NIH's Epidemiology and Disease Control Study Section, AHRQ Health Systems Research Study Section and the Institute of Medicine's Committee on Poison Prevention and Control.
PhD, Pharmacy, University of Minnesota 1979
MS, Pharmacy, University of Minnesota 1976
Shatin D, Gardner JS, Stergachis A, Blough D, Graham D. Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants. Pharmacoepi Drug Safety (in press).
Stergachis A, Gardner JS, Sullivan SD, Anderson MT. A randomized study on improving pediatric asthma outcomes in the community setting: does pharmaceutical care made a difference? J Am Pharm Assn 2002;42:743-52
Johnson ES, Platt R, Reiber G, Koepsell TH, Stergachis A. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002;55:253-59
Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Eng J Med 1996; 334:1362-6.